266 related articles for article (PubMed ID: 8625070)
1. Clinicopathologic spectrum of resected extraductal mass-forming intrahepatic cholangiocarcinoma.
Yamanaka N; Okamoto E; Ando T; Oriyama T; Fujimoto J; Furukawa K; Tanaka T; Tanaka W; Nishigami T
Cancer; 1995 Dec; 76(12):2449-56. PubMed ID: 8625070
[TBL] [Abstract][Full Text] [Related]
2. Combined hepatocellular carcinoma and cholangiocarcinoma: clinical features, treatment modalities, and prognosis.
Yin X; Zhang BH; Qiu SJ; Ren ZG; Zhou J; Chen XH; Zhou Y; Fan J
Ann Surg Oncol; 2012 Sep; 19(9):2869-76. PubMed ID: 22451237
[TBL] [Abstract][Full Text] [Related]
3. Combined hepatocellular and cholangiocarcinoma: clinical features and prognostic study in a Thai population.
Chantajitr S; Wilasrusmee C; Lertsitichai P; Phromsopha N
J Hepatobiliary Pancreat Surg; 2006; 13(6):537-42. PubMed ID: 17139428
[TBL] [Abstract][Full Text] [Related]
4. Protein expression of double-stranded RNA-activated protein kinase (PKR) in intrahepatic bile ducts in normal adult livers, fetal livers, primary biliary cirrhosis, hepatolithiasis and intrahepatic cholangiocarcinoma.
Terada T; Ueyama J; Ukita Y; Ohta T
Liver; 2000 Dec; 20(6):450-7. PubMed ID: 11169059
[TBL] [Abstract][Full Text] [Related]
5. Macroscopic types of intrahepatic cholangiocarcinoma: clinicopathologic features and surgical outcomes.
Hirohashi K; Uenishi T; Kubo S; Yamamoto T; Tanaka H; Shuto T; Kinoshita H
Hepatogastroenterology; 2002; 49(44):326-9. PubMed ID: 11995443
[TBL] [Abstract][Full Text] [Related]
6. First Reported Case of Primary Intrahepatic Cholangiocarcinoma with Pure Squamous Cell Histology: A Case Report.
Lubana SS; Singh N; Seligman B; Tuli SS; Heimann DM
Am J Case Rep; 2015 Jul; 16():438-44. PubMed ID: 26158884
[TBL] [Abstract][Full Text] [Related]
7. Clinicopathological prognostic factors after hepatectomy for patients with mass-forming type intrahepatic cholangiocarcinoma: relevance of the lymphatic invasion index.
Shirabe K; Mano Y; Taketomi A; Soejima Y; Uchiyama H; Aishima S; Kayashima H; Ninomiya M; Maehara Y
Ann Surg Oncol; 2010 Jul; 17(7):1816-22. PubMed ID: 20135355
[TBL] [Abstract][Full Text] [Related]
8. Clinicopathologic features of patients with intrahepatic cholangiocarcinoma who are seropositive for alpha-fetoprotein-L3 and those with combined hepatocellular and cholangiocarcinoma.
Okuda H; Shiratori K; Yamamoto M; Takasaki K; Nakano M
J Gastroenterol Hepatol; 2006 May; 21(5):869-73. PubMed ID: 16704538
[TBL] [Abstract][Full Text] [Related]
9. Hepatolithiasis in the hepatic hilum mimicking hilar cholangiocarcinoma: report of a case.
Senda Y; Nishio H; Ebata T; Yokoyama Y; Igami T; Sugawara G; Nagino M
Surg Today; 2011 Sep; 41(9):1243-6. PubMed ID: 21874423
[TBL] [Abstract][Full Text] [Related]
10. Proteomic profiling of cholangiocarcinoma: diagnostic potential of SELDI-TOF MS in malignant bile duct stricture.
Scarlett CJ; Saxby AJ; Nielsen A; Bell C; Samra JS; Hugh T; Baxter RC; Smith RC
Hepatology; 2006 Sep; 44(3):658-66. PubMed ID: 16941699
[TBL] [Abstract][Full Text] [Related]
11. CD10+ fibroblasts are more involved in the progression of hilar/extrahepatic cholangiocarcinoma than of peripheral intrahepatic cholangiocarcinoma.
Nishihara Y; Aishima S; Hayashi A; Iguchi T; Fujita N; Taketomi A; Honda H; Tsuneyoshi M
Histopathology; 2009 Oct; 55(4):423-31. PubMed ID: 19817893
[TBL] [Abstract][Full Text] [Related]
12. Cytokeratin 7 and 20 expression in cholangiocarcinomas varies along the biliary tract but still differs from that in colorectal carcinoma metastasis.
Rullier A; Le Bail B; Fawaz R; Blanc JF; Saric J; Bioulac-Sage P
Am J Surg Pathol; 2000 Jun; 24(6):870-6. PubMed ID: 10843291
[TBL] [Abstract][Full Text] [Related]
13. Histologic bile duct invasion by a mass-forming intrahepatic cholangiocarcinoma.
Hirohashi K; Uenishi T; Kubo S; Yamamoto T; Tanaka H; Shuto T; Yamasaki O; Horii K; Kinoshita H
J Hepatobiliary Pancreat Surg; 2002; 9(2):233-6. PubMed ID: 12140612
[TBL] [Abstract][Full Text] [Related]
14. Intrahepatic cholangiocarcinoma with increased serum CYFRA 21-1 level.
Kashihara T; Ohki A; Kobayashi T; Sato T; Nishizawa H; Ogawa K; Tako H; Kawakami F; Tsuji M; Tamaoka K
J Gastroenterol; 1998 Jun; 33(3):447-53. PubMed ID: 9658330
[TBL] [Abstract][Full Text] [Related]
15. Surgical treatment of patients with mixed hepatocellular carcinoma and cholangiocarcinoma.
Nakamura S; Suzuki S; Sakaguchi T; Serizawa A; Konno H; Baba S; Baba S; Muro H
Cancer; 1996 Oct; 78(8):1671-6. PubMed ID: 8859179
[TBL] [Abstract][Full Text] [Related]
16. Intrahepatic cholangiocarcinoma presenting intrabile duct tumor growth: report of a case.
Sano T; Yamamoto J; Kosuge T; Inoue K; Shimada K; Takayama T; Yamazaki S; Sakamoto M; Hirohashi S
Hepatogastroenterology; 1996; 43(9):667-70. PubMed ID: 8799413
[TBL] [Abstract][Full Text] [Related]
17. Serum CYFRA 21-1 in Biliary Tract Cancers: A Reliable Biomarker for Gallbladder Carcinoma and Intrahepatic Cholangiocarcinoma.
Huang L; Chen W; Liang P; Hu W; Zhang K; Shen S; Chen J; Zhang Z; Chen B; Han Y; Meng F; DeMorrow S; Yin X; Lai J; Liang L
Dig Dis Sci; 2015 May; 60(5):1273-83. PubMed ID: 25487191
[TBL] [Abstract][Full Text] [Related]
18. [Intrahepatic cholangiocarcinoma associated with hepatolithiasis].
Jeen YM; Jin SY
Korean J Hepatol; 2007 Sep; 13(3):423-6. PubMed ID: 17898560
[No Abstract] [Full Text] [Related]
19. [Pathology of cholangiocarcinoma].
Guedj N; Bedossa P; Paradis V
Ann Pathol; 2010 Dec; 30(6):455-63. PubMed ID: 21167432
[TBL] [Abstract][Full Text] [Related]
20. Intrahepatic Carcinosarcoma With Cholangiocarcinoma Elements and Prominent Bile Duct Spread.
Usui G; Hashimoto H; Kusakabe M; Shirota G; Sugiura Y; Fujita Y; Satou S; Harihara Y; Horiuchi H; Morikawa T
Int J Surg Pathol; 2019 Dec; 27(8):900-906. PubMed ID: 31203684
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
